EUTHANASIA SOLUTION CIII
Autor Name: Vedco, Inc.
Code Source: 50989-302
Route of Administration: INTRACARDIAC
EuthanasiaGeneric: pentobarbital sodium and phenytoin sodium
- pentobarbital sodium Pentobarbital : Active ingredient - basis of strength - 390 mg in 1 mL
- phenytoin sodium Phenytoin : Active ingredient - basis of strength - 50 mg in 1 mL
- 100 mL in 1 BOTTLE
FOR DOGS ONLY
CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian.
DESCRIPTIONA non-sterile solution containing pentobarbital sodium and phenytoin sodium as the active ingredients. Rhodamine B, a bluish-red fluorescent dye, is included in the formulation to help distinguish it from parenteral drugs intended for therapeutic use. Although the solution is not sterile, benzyl alcohol, a bacteriostat, is included to retard the growth of microorganisms.
Each mL contains: active ingredients: 390 mg pentobarbital sodium (barbituric acid derivative), 50 mg phenytoin sodium; inactive ingredients: 10% ethyl alcohol, 18% propylene glycol, 0.003688 mg rhodamine B, 2% benzyl alcohol (preservative), water for injection q.s. Sodium hydroxide and/or hydrochloric acid may be added to adjust pH.
ACTIONSEUTHANASIA SOLUTION (pentobarbital sodium and phenytoin sodium) contains two active ingredients which are chemically compatible but pharmacologically different. Each ingredient acts in such a manner so as to cause humane, painless, and rapid euthanasia. Euthanasia is due to cerebral death in conjunction with respiratory arrest and circulatory collapse. Cerebral death occurs prior to cessation of cardiac activity.
When administered intravenously, pentobarbital sodium produces rapid anesthetic action. There is a smooth and rapid onset of unconsciousness. At the lethal dose, there is depression of vital medullary respiratory and vasomotor centers.
When administered intravenously, phenytoin sodium produces toxic signs of cardiovascular collapse and/or central nervous system depression. Hypotension occurs when the drug is administered rapidly.
Pharmacodynamic ActivityThe sequence of events leading to humane, painless, and rapid euthanasia following intravenous injection of EUTHANASIA SOLUTION is similar to that following intravenous injection of pentobarbital sodium, or other barbituric acid derivatives. Within seconds, unconsciousness is induced with simultaneous collapse of the dog. This stage rapidly progresses to deep anesthesia with concomitant reduction in the blood pressure. A few seconds later, breathing stops, due to depression of the medullary respiratory center; encephalographic activity becomes isoelectric, indicating cerebral death; and then cardiac activity ceases.
Phenytoin sodium exerts its effect during the deep anesthesia stage caused by the pentobarbital sodium. This ingredient, due to its cardiotoxic properties, hastens the stoppage of electrical activity in the heart.
INDICATIONSFor use in dogs for humane, painless, and rapid euthanasia.
WARNINGFor canine euthanasia only. Must not be used for therapeutic purposes. Do not use in animals intended for food.
PRECAUTIONSEuthanasia may sometimes be delayed in dogs with severe cardiac or circulatory deficiencies. This may be explained by the impaired movement of the drug to its site of action. An occasional dog may elicit reflex responses manifested by motor movement; however, an unconscious animal does not experience pain, because the cerebral cortex is not functioning.
When restraint may cause the dog pain, injury, or anxiety, or danger to the person making the injection, prior use of tranquilizing or immobilizing drugs may be necessary.
DOSAGE AND ADMINISTRATION DosageDogs, 1 mL for each 10 pounds of body weight.
AdministrationIntravenous injection is preferred. Intracardiac injection may be made when intravenous injection is impractical, as in a very small dog, or in a comatose dog with impaired vascular functions. Good injection skill is necessary for intracardiac injection.
The calculated dose should be given in a single bolus injection.
For intravenous injection, a needle of sufficient gauge to insure intravenous placement of the entire dose should be used.
HOW SUPPLIEDEUTHANASIA SOLUTION is available in 100 mL multiple dose vials.
STORAGEStore between 15 ° and 30°C (59° and 86°F).
Manufactured for VEDCO, INC. , St. Joseph, MO 64507
For Technical Service contact (888) 708-3326.
ANADA #200-071, Approved by FDA
PRINCIPAL DISPLAY PANEL - 100 mL Vial CartonNDC 50989-302-12
FOR DOGS ONLY
NET CONTENTS: 100 mL
CAUTION: Federal law restricts
this drug to use by or on the order
of a licensed veterinarian.
ANADA #200-071, Approved by FDA
PRINCIPAL DISPLAY PANEL - 100 mL Vial Carton